- Home
- HELE vs ARVN Comparison
HELE vs ARVN Comparison
Compare HELE & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HELE
- ARVN
- Stock Information
- Founded
- HELE 1968
- ARVN 2015
- Country
- HELE United States
- ARVN United States
- Employees
- HELE N/A
- ARVN N/A
- Industry
- HELE Home Furnishings
- ARVN Biotechnology: Pharmaceutical Preparations
- Sector
- HELE Consumer Discretionary
- ARVN Health Care
- Exchange
- HELE Nasdaq
- ARVN Nasdaq
- Market Cap
- HELE 1.3B
- ARVN 614.8M
- IPO Year
- HELE N/A
- ARVN 2018
- Fundamental
- Price
- HELE $26.74
- ARVN $6.81
- Analyst Decision
- HELE Buy
- ARVN Buy
- Analyst Count
- HELE 3
- ARVN 19
- Target Price
- HELE $56.33
- ARVN $21.19
- AVG Volume (30 Days)
- HELE 914.1K
- ARVN 3.3M
- Earning Date
- HELE 04-24-2025
- ARVN 05-01-2025
- Dividend Yield
- HELE N/A
- ARVN N/A
- EPS Growth
- HELE N/A
- ARVN N/A
- EPS
- HELE 5.37
- ARVN N/A
- Revenue
- HELE $1,907,665,000.00
- ARVN $426,900,000.00
- Revenue This Year
- HELE $7.57
- ARVN N/A
- Revenue Next Year
- HELE $2.29
- ARVN N/A
- P/E Ratio
- HELE $4.98
- ARVN N/A
- Revenue Growth
- HELE N/A
- ARVN 498.74
- 52 Week Low
- HELE $24.15
- ARVN $5.94
- 52 Week High
- HELE $110.76
- ARVN $37.38
- Technical
- Relative Strength Index (RSI)
- HELE 30.76
- ARVN 36.29
- Support Level
- HELE $24.15
- ARVN $6.23
- Resistance Level
- HELE $28.62
- ARVN $8.00
- Average True Range (ATR)
- HELE 2.12
- ARVN 0.58
- MACD
- HELE 0.25
- ARVN -0.07
- Stochastic Oscillator
- HELE 20.84
- ARVN 16.81
About HELE Helen of Troy Limited
Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home & Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty & Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.